B. Boyce

Effects of Lubricant Level, Method of Mixing, and Duration of Mixing on a Controlled-Release Matrix Tablet Containing Hydroxypropyl Methylcellulose

P. Sheskey, R. T. Robb, R. Moore, 1995 .

USE OF ROLLER COMPACTION IN THE PREPARATION OF CONTROLLED-RELEASE HYDROPHILIC MATRIX TABLETS CONTAINING METHYLCELLULOSE AND HYDROXYPROPYL METHYLCELLUL OSE POLYMERS

P. Sheskey, R. T. Robb, B. Boyce, 1994 .

Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.

M. Lebwohl, B. Boyce, A. Menter, 2013, Journal of drugs in dermatology : JDD.

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial†

Kelly N. Taylor, Constance M. Brown, B. Elewski, 2019, The British journal of dermatology.

Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis.

B. Boyce, P. Anand, U. Anand, 2015, Acta dermato-venereologica.

Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis.

B. Boyce, P. Anand, U. Anand, 2015, Acta dermato-venereologica.